We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Biochip Simultaneously Tests for Three Thyroid Hormones

By Labmedica staff writers
Posted on 01 May 2008
Thyroid array biochips simultaneously test for three thyroid hormones in a single sample. The tests are performed an immunoassay analyzer that uses multi-analyte biochip array technology.

The integrated analyzer performs simultaneous quantitative detection of a wide range of protein analytes in a multi-analyte format. Evidence performs multiple immunoassays on each patient sample. The technology platform supports multiple different protein results, per person, on each biochip.

The Evidence immunoassay analyzer is a product of Randox Laboratories (Crumlin, UK). It offers the unique option of reflex reporting. If the thyroid-stimulating hormone (TSH) test result is within the normal range, only the TSH result is reported and the laboratory only pays for one test. If the TSH test result is elevated or low, the thyroxine and tri-iodothyronine test results are automatically reported as well. Reflex reporting offers a number of advantages: only one blood sample is required; the laboratory only performs one test procedure; and the laboratory only pays for the extra thyroid hormone tests when they are required.

TSH is released by the pituitary gland in the brain. Thyroxine (FT4 or TT4) and tri-iodothyronine (FT3 or TT3) are hormones produced by the thyroid gland. TSH is performed as the initial screening test, and all three hormones are essential in the diagnosis of thyroid disease.

The most common thyroid diseases are hyperthyroidism and hypothyroidism, affecting about 2% of the population. In hyperthyroidism, thyroid hormone levels are higher than normal; in hypothyroidism, thyroid hormone levels are low. Other thyroid conditions are goiter and thyroiditis. Thyroid cancer varies between slow-growing tumors with a good prognosis, to aggressive tumors with limited treatment options. Thyroid problems are about 10 times more common in women than in men.

Randox is an international diagnostics company that develops, manufactures, and markets clinical diagnostic products worldwide. Core products are: biochip array technology; clinical chemistry analyzers and reagents; quality controls and European quality assurance (EQA); environmental diagnostics; recombinant proteins and antibodies.


Related Links:
Randox

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE

Latest Clinical Chem. News

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
01 May 2008  |   Clinical Chem.

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
01 May 2008  |   Clinical Chem.

Low-Cost Portable Screening Test to Transform Kidney Disease Detection
01 May 2008  |   Clinical Chem.